Drug intelligence / Profile preview

Vacuna Acuosa

Development stage
Unknown
Lead developer
Alergo Pharma
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

Vacuna Acuosa is an injectable allergen immunotherapy product developed by Alergo Pharma, an Argentinian company acquired by Stallergenes in 2014. It consists of unmodified allergen extracts diluted in an aqueous saline solution. The product is administered via subcutaneous injection to induce immunological tolerance and desensitize the immune system through repeated exposure to specific allergens. It is indicated for the treatment of allergic diseases, including allergic rhinitis, allergic asthma, and allergic conjunctivitis. As a traditional unmodified aqueous extract, it typically requires more frequent dosing compared to modified depot or polymerized formulations due to its immediate release profile and shorter stability.

Brand names
Vacuna Acuosa
Other names
Injectable aqueous vaccineUnmodified aqueous saline allergen extract

Beyond the preview

Go deeper on Vacuna Acuosa.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vacuna Acuosa.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call